When it Comes to Pharmaceutical Research, Canada is Missing Out
John Bergeron
McGill board demands funds be restored
McGill University’s board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government’s action is “excessive and injurious” to the university.
National network evaluating drug safety reports early results
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada.
Fixing the other Health Care Issue; Unique Challenges
"Despite high per-capita spending, health care in Canada consistently underperforms, according to the Commonwealth Fund, which tracks indicators for accessibility, timeliness and outcomes across a number of developed countries. The system that is straining to meet demand today will face an even higher burden in the years ahead, as the population ages.